Signaling Pathway
Perakizumab (RG4934) is a humanized IgG1?? monoclonal antibody specifically targeting IL-17A, a cytokine implicated in the pathogenesis of various autoimmune disorders. This antibody is utilized primarily in the investigation of autoimmune diseases including psoriatic arthritis, offering a valuable tool for elucidating disease mechanisms and potential therapeutic pathways.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Perakizumab (RG4934) is a humanized IgG1?? monoclonal antibody specifically targeting IL-17A, a cytokine implicated in the pathogenesis of various autoimmune disorders. This antibody is utilized primarily in the investigation of autoimmune diseases including psoriatic arthritis, offering a valuable tool for elucidating disease mechanisms and potential therapeutic pathways. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
